Literature DB >> 24905310

Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress.

Cüneyt Türkeş1, Hakan Söyüt2, Sükrü Beydemir3.   

Abstract

BACKGROUND: In this study, we investigated the in vitro effects of calcium channel blockers (nifedipine, nitrendipine, isradipine, and amlodipine besylate) on the activity of paraoxonase-1 (PON1).
METHODS: PON1 was purified from human serum using simple chromatographic methods, including DEAE-Sephadex anion-exchange and Sephadex G-200 gel filtration chromatography.
RESULTS: The calcium channel blockers decreased the in vitro PON1 activity. The inhibition mechanism of amlodipine besylate was noncompetitive, whereas nifedipine, nitrendipine, and isradipine were competitive inhibitors.
CONCLUSIONS: Our results showed that calcium channel blockers exhibit inhibitory effects on PON1 at low concentrations. The IC(50) values for nifedipine, nitrendipine, isradipine, and amlodipine besylate were determined to be 0.121 mM, 0.130 mM, 0.255 mM, and 0.304 mM, respectively, and the K(i) constants were calculated to be 0.222 ± 0.049 mM, 0.151 ± 0.067 mM, 0.286 ± 0.137 mM, and 0.321 ± 0.002 mM, respectively.
Copyright © 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Amlodipine besylate; Isradipine; Nifedipine; Nitrendipine; Paraoxonase

Mesh:

Substances:

Year:  2014        PMID: 24905310     DOI: 10.1016/j.pharep.2013.08.007

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  2 in total

1.  Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif.

Authors:  Özcan Güleç; Cüneyt Türkeş; Mustafa Arslan; Yeliz Demir; Yeşim Yeni; Ahmet Hacımüftüoğlu; Ergün Ereminsoy; Ömer İrfan Küfrevioğlu; Şükrü Beydemir
Journal:  Mol Divers       Date:  2022-04-09       Impact factor: 3.364

2.  Olmesartan Combined With Amlodipine on Oxidative Stress Parameters in Type 2 Diabetics, Compared With Single Therapies: A Randomized, Controlled, Clinical Trial.

Authors:  Giuseppe Derosa; Amedeo Mugellini; Rosa Maria Pesce; Angela D'Angelo; Pamela Maffioli
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.